Xinhua
01 Dec 2021, 14:05 GMT+10
SYDNEY, Dec. 1 (Xinhua) -- Research institutes and pharmaceutical company in Australia's state of Victoria have created a new mRNA COVID vaccine candidate, with clinical trials to begin early next year.
The vaccine candidate, developed by Monash University researchers, pharmaceutical manufacturer IDT Australia and the Peter Doherty Institute for Infection and Immunity, is expected to provide protection against future COVID variants.
Professor Colin Pouton from Monash University, who led the team that developed the vaccine, said on Tuesday that this vaccine has the ability to rapidly adjust its composition in response to emerging virus mutations, which is particularly important as new strains continue to emerge.
Compared with the existing vaccines, the new candidate focuses on a small part of the spike protein, known as the receptor-binding domain (RBD), which mediates the virus's ability to attach and enter the cell.
Through targeting the RBD region, the vaccine candidates focus the immune system on blocking virus attachment and infection.
Pouton said this approach makes it a more focused vaccine with the important ability to rapidly adjust its composition in response to emerging mutations, including the new variant Omicron -- if the virus mutates, a new vaccine can be tested within a few weeks.
"The new variant Omicron has an unprecedented number of mutations in its receptor-binding domain. How concerned we should be about this variant remains to be seen, but our RBD mRNA vaccine program is perfectly suited to producing a specific vaccine to protect against this new variant," he said.
Associate Professor Archa Fox, an mRNA researcher at the University of Western Australia and president of the RNA Network of Australia, said the vaccine candidate is a significant step forward towards Australia's first home-grown mRNA vaccine, as the country cannot always rely on the global supply.
"Because of the high cost of buying vaccines from overseas, and the potential to be at the back of the queue for future pandemics, we urgently need to build expertise, capacity and capability in Australia to make mRNA vaccines and RNA therapeutics more broadly," said Fox.
About 450 doses of the vaccine candidate have been manufactured, enabling 150 people to take part in Phase 1 clinical trials, with results expected in later 2022.
Get a daily dose of Perth Herald news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Perth Herald.
More InformationREDMOND, Washington: Microsoft President Brad Smith said there is no chance of super-intelligent artificial intelligence (AI) being developed within the ...
The Russian envoy has held talks with the chief of Gujarat, which contains India's largest refineries and an upcoming financial ...
As worries mount about unsustainable levels of debt in the Chinese economy, a major ratings firm on Tuesday announced that ...
Isan region, Thailand - Twenty-three Thai citizens have returned home from a weeks-long ordeal in Gaza; Hamas had taken the ...
Islamabad [Pakistan], December 6 (ANI): Pakistan's National Electric Power Regulatory Authority (NEPRA) on Tuesday approved a Pakistani rupee (PKR) 3.07 ...
Abu Dhabi [UAE], December 6 (ANI/WAM): UAE Banks Federation (UBF) reaffirmed its commitment to support UAE's goals by pledging to ...
The national accounts released by the Australian Bureau of Statistics show economic growth slid to a measly 0.2% in the ...
The principle is vital to cross-Strait stability, a Foreign Ministry spokesperson has saidThe Taiwan question is exclusively China's internal affair, ...
Millions around the world turn to Wikipedia when they want to better understand the world around them, and that apparently ...
New Delhi [India], December 6 (ANI): Arguably among the best in his trade across cricketing generations, star India speedster Jasprit ...
The ?one-China principle? is the solid anchor to cross-Strait stability, a Foreign Ministry spokesperson has saidThe Taiwan question is exclusively ...
Mumbai (Maharashtra) [India], December 5 (ANI): After the end of the five-match T20I series between India and Australia on December ...